BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 2537406)

  • 1. Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
    Mei L; Lai J; Roeske WR; Fraser CM; Venter JC; Yamamura HI
    J Pharmacol Exp Ther; 1989 Feb; 248(2):661-70. PubMed ID: 2537406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between agonist states of the M1 muscarinic receptor and the hydrolysis of inositol lipids in transfected murine fibroblast cells (B82) expressing different receptor densities.
    Mei L; Lai J; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1989 Oct; 251(1):90-7. PubMed ID: 2795474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological comparison of the cloned human and rat M2 muscarinic receptor genes expressed in the murine fibroblast (B82) cell line.
    Kovacs I; Yamamura HI; Waite SL; Varga EV; Roeske WR
    J Pharmacol Exp Ther; 1998 Feb; 284(2):500-7. PubMed ID: 9454790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways.
    Zhang LB; Buxton IL
    Mol Pharmacol; 1991 Dec; 40(6):952-9. PubMed ID: 1661840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand binding and functional characterization of muscarinic acetylcholine receptors on the TE671/RD human cell line.
    Bencherif M; Lukas RJ
    J Pharmacol Exp Ther; 1991 Jun; 257(3):946-53. PubMed ID: 1646330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The m2 muscarinic acetylcholine receptors are coupled to multiple signaling pathways via pertussis toxin-sensitive guanine nucleotide regulatory proteins.
    Lai J; Waite SL; Bloom JW; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1991 Sep; 258(3):938-44. PubMed ID: 1653846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic cholinergic ligand binding to intact mouse pituitary tumor cells (AtT-20/D16-16) coupling with two biochemical effectors: adenylate cyclase and phosphatidylinositol turnover.
    Akiyama K; Vickroy TW; Watson M; Roeske WR; Reisine TD; Smith TL; Yamamura HI
    J Pharmacol Exp Ther; 1986 Mar; 236(3):653-61. PubMed ID: 3005550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M2 muscarinic receptor subtype is associated with inositol trisphosphate accumulation, myosin light chain phosphorylation and contraction in sphincter smooth muscle of rabbit iris.
    Akhtar RA; Honkanen RE; Howe PH; Abdel-Latif AA
    J Pharmacol Exp Ther; 1987 Nov; 243(2):624-32. PubMed ID: 3500300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
    Xu J; Chuang DM
    J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic cholinoceptor activation modulates DNA synthesis and CD40 expression in fibroblast cells.
    Casanova M; Furlán C; Sterin-Borda L; Borda ES
    Auton Autacoid Pharmacol; 2006 Jul; 26(3):293-301. PubMed ID: 16879495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
    Brown JH; Goldstein D; Masters SB
    Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic comparison of selected agonists for the M1 muscarinic receptor in transfected murine fibroblast cells (B82).
    Mei L; Lai J; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1991 Feb; 256(2):689-94. PubMed ID: 1704434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
    McKinney M; Stenstrom S; Richelson E
    Mol Pharmacol; 1984 Sep; 26(2):156-63. PubMed ID: 6148690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological coupling and functional role for the muscarinic receptor subtypes in isolated cells from the circular smooth muscle of the rabbit cecum.
    Cuq P; Magous R; Bali JP
    J Pharmacol Exp Ther; 1994 Oct; 271(1):149-55. PubMed ID: 7965708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic regulation of cyclic AMP in bovine trachealis cells.
    Schaefer OP; Ethier MF; Madison JM
    Am J Respir Cell Mol Biol; 1995 Aug; 13(2):217-26. PubMed ID: 7626289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of muscarinic receptors in the uterus of oestrogen-primed and pregnant rats.
    Munns M; Pennefather JN
    Br J Pharmacol; 1998 Apr; 123(8):1639-44. PubMed ID: 9605571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptors on intact human fibroblasts. Absence of receptor activity in adult skin cells.
    Van Riper DA; Absher MP; Lenox RH
    J Clin Invest; 1985 Aug; 76(2):882-6. PubMed ID: 2993368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic characterization of muscarinic receptors of insect brains.
    Abdallah EA; Eldefrawi ME; Eldefrawi AT
    Arch Insect Biochem Physiol; 1991; 17(2-3):107-18. PubMed ID: 1802028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation.
    Meeker RB; Harden TK
    Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.